These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activity of ceftolozane-tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata - SMART United States 2016-2017. Lob SH, Hoban DJ, Young K, Motyl MR, Sahm DF. J Glob Antimicrob Resist; 2020 Mar; 20():209-213. PubMed ID: 31351246 [Abstract] [Full Text] [Related]
11. In Vitro Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa. Goodlet KJ, Nicolau DP, Nailor MD. Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865 [Abstract] [Full Text] [Related]
14. Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018. Shortridge D, Streit J, Pfaller M, Tulloch M, Chen WT, Castanheira M. J Glob Antimicrob Resist; 2022 Dec; 31():98-103. PubMed ID: 35988706 [Abstract] [Full Text] [Related]